Sumitomo Seika Chemicals Company, Limited.
Stock Price Chart
2026/08/21 UpdatedPrice Trend
2026/08/21 UpdatedPrice & Trading Details
2026/08/21 UpdatedPRICE
TRADING
Earnings Calendar
Updated 2026/08/01Recent Earnings
| Date | EPS Est. | EPS Actual | Surprise |
|---|---|---|---|
| 2016/02/03 | ¥26.71 | ¥26.18 | -2.0% |
| 2015/08/02 | ¥21.88 | ¥15.30 | -30.1% |
| 2015/05/11 | ¥19.56 | ¥8.90 | -54.5% |
| 2015/02/03 | ¥21.62 | ¥31.32 | +44.9% |
Shareholder Composition
Updated 2026/08/01Major Holders
Updated 2026/08/01| Institution | Ownership | Shares | Change |
|---|---|---|---|
|
Price (T.Rowe) International Discovery Fund
|
652.7K | 0.00% | |
|
DFA International Small Cap Value Portfolio
|
138.9K | +4.20% | |
|
Vanguard International Stock Index-Total Intl Stock Indx
|
102.6K | -26.46% | |
|
Price (T.Rowe) International Small-Cap Equity Trust
|
94.0K | +3.18% | |
|
Vanguard Tax Managed Fund-Vanguard Developed Markets Index Fund
|
66.0K | +13.60% | |
|
DFA Japanese Small Company Series
|
53.6K | -4.96% |
Dividend History
Updated 2026/08/23| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥24 | -40.0% |
| 2025 | ¥40 | 0.0% |
| 2024 | ¥40 | 0.0% |
| 2023 | ¥40 | +25.0% |
| 2022 | ¥32 | - |
Financial Performance
2026/08/23 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥143,041M | ¥142,986M | ¥147,571M | ¥148,354M |
| Gross Profit | ¥30,135M | ¥28,007M | ¥30,681M | ¥35,435M |
| Operating Income | ¥10,459M | ¥9,532M | ¥10,715M | ¥14,467M |
| Pretax Income | ¥11,535M | ¥9,119M | ¥8,608M | ¥11,957M |
| Net Income | ¥8,592M | ¥6,166M | ¥5,961M | ¥7,677M |
| EPS | ¥127.37 | ¥91.80 | ¥90.12 | ¥117.48 |
| Operating Margin | 7.31% | 6.67% | 7.26% | 9.75% |
| Balance Sheet | ||||
| Total Assets | ¥126,651M | ¥136,305M | ¥141,532M | ¥152,732M |
| Total Equity | ¥86,660M | ¥95,051M | ¥94,312M | ¥103,619M |
| Total Liabilities | ¥39,991M | ¥41,254M | ¥47,220M | ¥49,113M |
| Cash | ¥23,553M | ¥21,662M | ¥16,863M | ¥18,217M |
| Interest-bearing Debt | ¥12,623M | ¥11,569M | ¥18,863M | ¥17,933M |
| Equity Ratio | 68.42% | 69.73% | 66.64% | 67.84% |
| D/E Ratio | 0.15 | 0.12 | 0.20 | 0.17 |
| Cash Flow | ||||
| Operating CF | ¥6,703M | ¥12,008M | ¥13,681M | ¥17,480M |
| Investing CF | -¥5,942M | -¥10,372M | -¥20,915M | -¥11,331M |
| Financing CF | -¥8,303M | -¥5,767M | ¥3,186M | -¥5,091M |
| Free CF | -¥128M | ¥2,036M | -¥7,398M | ¥4,215M |
| Efficiency | ||||
| ROE | 9.91% | 6.49% | 6.32% | 7.41% |
| ROA | 6.78% | 4.52% | 4.21% | 5.03% |
Latest IR Information
-
(Correction) Formulation of the 'Long-term Vision Toward 2045' and the 'Outline of the New Medium-term Management Plan (2026–2030)'
Amendments to the outline of the new medium-term management plan and the management targets for 2030 have been disclosed. The revised figures include: net sales of 200 billion yen, operating income of 17.5 billion yen, net income of 12.4 billion...
Read more -
Formulation of the 'Long-Term Vision for 2045' and the 'Key Points of the New Medium-Term Management Plan (FY2026–2030)'
Formulation of the 2045 long-term vision and the core elements of the new medium-term management plan for FY2030. The long-term vision centers on 'creating the future as a chemical company with technology and quality,' outlining key challenges and growth strategies....
Read more -
Notice of Changes to Dividend Policy (DOE Introduction) and Revisions to Dividend Forecast
In line with the new medium-term management plan, DOE is introduced. Based on a payout ratio of at least 30% and DOE of at least 4.5%, internal reserves will be allocated to growth investment. The per-share dividend forecast for the...
Read more -
Notice on Full-Year Earnings Forecast for the Fiscal Year Ending March 2027
Discloses the full-year consolidated earnings forecast for the fiscal year ending March 2027. Net sales are 165,000 hundred million yen, operating profit 11,000 hundred million yen, ordinary profit 11,200 hundred million yen, net income attributable to owners of the parent...
Read more -
For the Fiscal Year Ending March 2027, First Quarter Consolidated Financial Summary (Japanese GAAP) (Interim)
Consolidated results for the first quarter of the fiscal year ending March 2027 show net sales of 40,397 million yen, up 13.6% YoY; operating income of 3,452 million yen, up 47.5% YoY; ordinary income of 4,315 million yen, up 168.5%...
Read more
Latest News (5 items)
Company Information
About
Sumitomo Seika Chemicals Company, Limited. engages in the manufacture and sale of absorbent polymers, functional chemicals, and gases in Japan and internationally. It operates through the Super Absorbent Polymers and Functional Materials segments. The Super Absorbent Polymers segment offers a super absorbent polymer, AQUA KEEP, used in water absorbent materials for hygiene products, including disposable diapers, baby diapers, sanitary napkins, and incontinent pad; industrial materials comprising water blocking tape for power and optical cables and water-swelling rubber; and other applications, such as water absorbent pad, freshness agent, water retention agent, anti-dewing agent, pet sheets, and water absorbent sheets. Its Functional Materials segment manufactures and sells water soluble polymers, emulsions, latexes, powder resins, and organic synthetic chemicals. This segment also produces particle polymers, pharmaceuticals-related products, functional products, electronics gases, standard gases, industrial chemicals, medical gases, chemical gases, oxygen, nitrogen, hydrogen, and other gas generators, including PSA systems. The company was incorporated in 1944 and is headquartered in Osaka, Japan.
